Ontario health officials have announced they will be no longer administering the AstraZeneca COVID-19 vaccine as a first dose option, due to increased concerns of the vaccine’s link to blood clots.
Ontario health officials have announced they will be no longer administering the AstraZeneca COVID-19 vaccine as a first dose option, due to increased concerns of the vaccine’s link to blood clots.
The Public Health Agency of Canada says it has received a report of a blood clot after a Quebec woman received the Oxford-AstraZeneca vaccine.